101. LACE+ Index as Predictor of 30-Day Readmission in Brain Tumor Population
- Author
-
Stephen Goodrich, Scott D. McClintock, Ian F. Caplan, Neil R. Malhotra, Benjamin Osiemo, David Kung, Gregory Glauser, Patricia Zadnik Sullivan, Donald M. O'Rourke, and Omar Choudhri
- Subjects
Adult ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Population ,Brain tumor ,Comorbidity ,Logistic regression ,Patient Readmission ,Odds ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Medicine ,Humans ,education ,Craniotomy ,Aged ,Aged, 80 and over ,education.field_of_study ,Receiver operating characteristic ,business.industry ,Brain Neoplasms ,Supratentorial Neoplasm ,Emergency department ,Length of Stay ,Middle Aged ,medicine.disease ,Hospitals ,Patient Discharge ,Hospitalization ,Logistic Models ,ROC Curve ,030220 oncology & carcinogenesis ,Surgery ,Female ,Neurology (clinical) ,business ,Emergency Service, Hospital ,030217 neurology & neurosurgery - Abstract
The LACE+ index (Length of stay, Acuity of admission, Charlson Comorbidity Index score, and Emergency department [ED] visits in the past 6 months) is a tool used to predict 30-day readmissions. We sought to examine this predictive tool in patients undergoing brain tumor surgery.Admissions and readmissions for patients undergoing craniotomy for supratentorial neoplasm at a single multihospital academic medical center were analyzed. All brain tumor cases for which the patient was alive at 30 days after surgery were included (n = 352). Simple logistic regression analyses were used to assess the ability of the LACE+ index and subsequent single variables to accurately predict the outcome measures of 30-day readmission, reoperation, and ED visit. Analysis of the model's or variable's discrimination was determined by the receiver operating characteristic curve as represented by the C-statistic.The sample included admissions for craniotomy for supratentorial neoplasm (n = 352). Assessment of the LACE+ index demonstrates a 1.02× increased odds of 30-day readmission for every 1-unit increase in LACE+ score (P = 0.031, CI = 1.00-1.03). Despite this, analysis of the receiver operating characteristic curve indicates that LACE+ index has poor specificity in predicting 30-day readmission (C-statistic = 0.58). A 1-unit increase in LACE+ score also predicts a 0.98× reduction in odds of home discharge (P0.001, CI = 0.97-0.99, C-statistic = 0.70). But LACE+ index does not predict 30-day reoperation (P = 0.945) or 30-day ED visits (P = 0.218).The results of this study demonstrate that the LACE+ index is not yet suitable as a prediction model for 30-day readmission in a brain tumor population.
- Published
- 2019